Five-Year LOE Impact Approaches $200bn
Stelara, Eylea, Vyvanse And Xarelto Among Key Targets For Biosimilars And Generics To 2028
• By David Wallace
The impact of LOEs for the leading 10 developed markets from 2024 to 2028 is nearing $200bn • Source: Shutterstock 
